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Methods for assessing ki-nase activities have relied on the transfer of a radio-
active γ-phosphoryl moiety from ATP 
to substrate and have been very use-
ful for in vitro studies of kinases. How-
ever, beyond being discontinuous, 
this assay is incompatible with unfrac-
tionated cell lysates since ATP is a 
common substrate for most kinases. 
This has prompted the development 
of protein-based fluorescence reso-
nance energy transfer (FRET) sen-
sors for probing kinase activity (1-3). 
While useful, these FRET-based sen-
sors produce modest changes in fluo-
rescence upon phosphorylation. Alter-
natively, the development of methods 
based on small organic fluorophores 
has provided sensitive probes for inter-
rogating biological functions (4, 5). Re-
cently our laboratory has introduced a 
direct kinase assay strategy based on 
chelation-enhanced fluorescence of a 
cysteine derivative of a sulfonamido-
oxine fluorophore (6), which we term 
CSox (Figure 1, panel a). Placed (−)2 
or (+)2 relative to the phosphorylation 
site in an optimized kinase substrate, 
the CSox amino acid provides a read-
ily observable increase in fluorescence 
signal in response to phosphorylation 
due to chelation of Mg2+ between the 
newly installed phosphoryl group and 
CSox. These probes afford sensitive 
real-time fluorescence readouts of ki-
nase activity in unfractionated cell ly-
sates (7, 8), provided that selective 
substrate sequences for the kinase of 
interest can be identified (5, 9, 10).
Recently p38α, a member of the 
mitogen-activated protein kinase 
(MAPK) family, has been the target 
of a variety of drug development ef-
forts (11, 12) since inhibitors of this ki-
nase may provide treatments for in-
flammatory diseases (13). Additionally, 
increased activation of p38α in tumor 
tissue derived from patients with non-
small cell lung carcinoma has been 
observed (14, 15). Consequently, with 
the goal of developing a direct p38α 
chemosensor that would be compati-
ble with unfractionated cell lysates, we 
investigated strategies for generating 
selective substrates for MAPKs.
In the case of MAPKs the develop-
ment of selective probes has proved 
more challenging due to the minimal 
local consensus phosphorylation se-
quence, S/T-P. This class of enzymes 
(including the ERK, JNK, and p38 
family members) derives specificity 
through the use of extended protein or 
peptide docking domains that are dis-
tal to the phosphorylation site (16, 17). 
These docking domains serve to tar-
get a substrate to a particular kinase 
and can therefore be viewed as unique 
address elements. Due to the limited 
structural information concerning p38α 
substrates, we chose to employ a strat-
egy in which a known docking pep-
tide sequence (18, 19) (Figure 1, panel 
b) would be linked to a CSox-based 
phosphorylation site via a flexible linker 
(16) (Figure 1, panel c). Initial phos-
phorylation reactions indicated that this 
sensor, MEF2A-CSox, could act as a 
substrate for purified p38α (Supple-
mentary Figure S1). Phosphor ylation 
reactions containing differing amounts 
of MEF2A-CSox demonstrated a KM 
and Vmax for p38α of 1.3 μM and 1.1 
μmol mg−1 min−1, respectively  
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Abstract
Recent efforts have identified the p38α 
Ser/Thr kinase as a potential target for 
the treatment of inflammatory diseases 
as well as non-small cell lung carci-
noma. Despite the significance of p38α, 
no direct activity probe compatible with 
cell lysate analysis exists. Instead, prox-
ies for kinase activation, such as phos-
phospecific antibodies, which do not dis-
tinguish between p38 isoforms, are often 
used. Our laboratory has recently de-
veloped a sulfonamido-oxine (Sox) fluo-
rophore that undergoes a significant in-
crease in fluorescence in response to 
phosphorylation at a proximal residue, 
allowing for real-time activity measure-
ments. Herein we report the rational de-
sign of a p38α-selective chemosensor 
using this approach. We have validated 
the selectivity of this sensor using spe-
cific inhibitors and immunodepletions 
and show that p38α activity can be mon-
itored in crude lysates from a variety of 
cell lines, allowing for the potential use 
of this sensor in both clinical and basic 
science research applications.
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(Figure 2, panel a). We then assessed 
the specificity of MEF2A-CSox by ex-
posing it to a panel of related kinases 
(Figure 2, panel b). MEF2A-CSox was 
selectively phosphorylated by p38α 
and showed minimal background ac-
tivity in the presence of the closely re-
lated p38β isoform (8%) and the re-
maining kinase panel. Importantly, 
this difference in selectivity for p38α 
over p38β translated into a 17-fold en-
hancement in catalytic efficiency for 
p38α (Supplementary Figure S2). En-
couraged by these in vitro studies, 
we investigated the ability of MEF2A-
CSox to report p38α activation in un-
fractionated cell lysates.
Several studies have demonstrated 
p38α activation in response to inflam-
matory cytokines or cellular stress 
(20). With this in mind, we treated 
HeLa cells with increasing amounts 
of the cytokine TNFα (Supplementary 
Figure S3). These initial experiments 
demonstrated that MEF2A-CSox was 
capable of reporting p38α activa-
tion despite appreciable signal due to 
phosphorylation by off-target kinases. 
A recent survey of kinase inhibitors 
(21) indicated that the broad spectrum 
inhibitor staurosporine is not effective 
against p38α, which was confirmed 
using recombinant enzyme (Supple-
mentary Figure S4). Consequently we 
hypothesized that, in this case, stauro-
sporine may be used to reduce the  
off-target kinase activities allowing for 
discrimination of the p38α signal. In-
deed, the addition of 1 μM staurospo-
rine to assays using sorbitol-stimulated 
lysates demonstrated that a portion of 
off-target kinases could be suppressed 
by using this promiscuous inhibitor 
(Figure 3, panel a), and therefore stau-
rosporine was added to all subsequent 
lysate assays. A comparison between 
TNFα and sorbitol stimulation indi-
cated an increase of 68% in the rate of 
MEF2A-CSox phosphorylation in cells 
stimulated by osmotic shock (Figure 
3, panel b), and consequently these 
lysates were used to optimize assay 
conditions. Optimal signal-to-noise 
for sorbitol-stimulated lysates was ob-
tained using 10 μg of total protein 
(Supplementary Figure S5), which pro-
vided a clearly discernible enhance-
ment in the rate of phosphorylation of 
MEF2A-CSox (Figure 3, panel c). Us-
ing small molecule inhibitors of p38α, 
specifically SB203580, which is 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ATP competitive (22-24), and 
BIRB796, a slow-binding allosteric in-
hibitor (25), the origin of the increase 
in the rate of MEF2A-CSox phosphor-
ylation upon osmotic shock was inves-
tigated. The addition of 1 μM of each 
of these compounds, which completely 
abolishes activity of recombinant  
kinase (Supplementary Figure S6),  
reduced the rate of phosphorylation of 
MEF2A-CSox in sorbitol-stimulated 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HeLa lysates to levels observed for se-
rum starved cells (Figure 3, panel d). 
Appropriate control measurements es-
tablished that this effect was not due 
to the inhibitor solvent (DMSO) (Sup-
plementary Figure S7).
We sought to further verify the se-
lectivity of MEF2A-CSox for p38α 
through a series of inhibition studies, 
immunodepletion experiments, and 
analyses across different cell lines
Figure 1. Rational design of a p38α chemosensor. a) A schematic of the chelation-en-
hanced fluorescence of the CSox amino acid upon phosphorylation. b) Crystal structure 
of the MEF2A docking peptide bound to p38α (left) and distances in Å from the C-termi-
nus of the docking peptide to representative distal regions of the catalytic and substrate-
binding domains of the kinase (right) (18). c) Amino acid sequence of the MEF2A-CSox 
sensor with the position of CSox (blue) and the site of phosphorylation (red) indicated. 
The flexible 8-amino-3,6-dioxaoctanoic acid (AOO) linker is also shown.
Figure 2. MEF2A-CSox is a substrate for recombinant p38α. a) Direct fit of a velocity ver-
sus MEF2A-CSox concentration plot using the Briggs−Haldane equation. b) Phosphory-
lation reactions were conducted with the indicated recombinant kinase (15 nM) using 1 
μM substrate and demonstrate that MEF2A-CSox is selective for p38α among these ki-
nases. The inset shows the average reaction slope for each kinase.
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Accordingly, the phosphorylation of 
MEF2A-CSox was determined in the 
presence of varying concentrations 
of SB203580 and BIRB796 (Figure 4, 
panels a and b, respectively). A con-
centration-dependent decrease in the 
rate of phosphorylation of MEF2A-
CSox was observed in the presence 
of SB203580, yielding a Ki of 7.5 nM, 
which reflects the reported Ki of 21 
nM (24). A similar dose-dependent re-
sponse was observed for BIRB796  
that was in good correlation with pre-
viously reported values (25). Impor-
tantly, these experiments indicate that 
the remaining background activity due 
to off-target kinases could be essen-
tially eliminated through background 
subtraction of parallel reactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
containing 1 μM SB203580 (see also 
Figure 3, panel d). Accordingly, to fur-
ther verify the specificity of MEF2A-
CSox, p38α immunodepletion studies 
were performed in which the activ-
ity remaining after the addition of 
SB203580 was used for background 
subtraction. These depletions clearly 
demonstrate that the increase in the 
rate of phosphorylation of MEF2A-
CSox upon stimulation by osmotic 
shock is predominantly due to p38α 
(Figure 4, panel c). Moreover, similar 
depletions for the related kinase ERK5 
(26) demonstrated no appreciable loss 
of signal (Supplementary Figure S8). 
In combination with the known selec-
tivity profiles for the inhibitors used 
herein (21) (Supplementary Table S1), 
these results indicate that MEF2A-
CSox is a p38α-selective activity probe 
and that off-target signal can be virtu-
ally eliminated using SB203580.
Finally, we investigated the abil-
ity of MEF2A-CSox to report the acti-
vation of p38α in a variety of cell lines 
isolated from different tissues and spe-
cies. Indeed MEF2A-CSox was capa-
ble of reporting the activation of p38α 
in HeLa (human), Cos7 (simian), and 
NIH-3T3 (rodent) cells (Figure 4, panel 
d). The activity in each lysate corre-
lated with Western blot analyses indi-
cating that MEF2A-CSox can be used 
in a variety of mammalian systems 
and tissues to directly interrogate p38α 
activity levels.
We have designed and validated 
the first isoform-selective p38 activ-
ity probe compatible with unfraction-
ated cell lysates. This probe provides 
isoform-specific activity information 
that cannot be obtained through the 
use of currently available phosphospe-
cific antibodies. Because the synthe-
sis described herein produces 2.4 mg 
of MEF2A-CSox, sufficient material for 
7,000 assays in 96-well plate format or 
28,000 assays in 384-well format (7), 
this sensor could easily be utilized to 
rapidly screen compound libraries to 
identify p38α inhibitors. Furthermore, 
we envision that this sensor will be 
useful for detailing the changes in ki-
nase signaling pathways during cellu-
lar transformations such as differentia-
tion and cancer development (15).
Methods
General Reagents and Methods. Low 
metals grade chemicals were obtained from 
Sigma and Alfa Aesar. Lysates were nor-
malized for total protein content using the 
Bio-Rad protein assay (500−0006) with 
BSA as a standard. Fluorescence emis-
sion was acquired at 485 nm using 360 nm 
excitation on either a HTS 7000 Bio As-
say Reader (Perkin-Elmer) or Spectramax 
Gemini XS (Molecular Devices, 455 nm 
cutoff) plate reader. All fluorescence assays 
were performed at 30 °C in 96-well plates 
(Corning, 3992).
Synthesis of MEF2A-Csox. MEF2A-
CSox was synthesized using standard 
Fmoc-based solid-phase peptide synthe-
sis methods as described previously (6). 
The linker in MEF2A-CSox was installed by 
coupling three Fmoc-protected AOO link-
ers (Novabiochem, 851037) to the growing 
peptide chain on 100 mg of PAL-PEG-PS 
resin (0.19 mmol g−1 substitution, Applied 
Biosystems). The Sox fluorophore was  
Figure 3. Reducing off-target phosphorylation of MEF2A-CSox in unfractionated cell ly-
sates. a) Reactions were conducted using 1 μM substrate and 10 μg of the indicated 
HeLa lysate with or without the addition of staurosporine. The inset shows a Western blot 
analysis of the indicated lysates, demonstrating p38 activation upon stimulation. b) Rela-
tive reaction slopes obtained using 1 μM substrate and 5 μg of the indicated lysates. The 
inset shows a Western blot analysis of each lysate. c) Initial phosphorylation reactions 
using 10 μg of total cellular protein from the indicated HeLa cell lysate demonstrated 
that MEF2A-CSox (1 μM) could report on the presence of active p38. Data is corrected 
for lag times. d) Assays were performed using lysates from serum-starved or stimulated 
cells (10 μg) with MEF2A-CSox (1 μM). Inhibitors of p38α were added to the reactions 
containing lysates from stimulated cells where indicated. All reactions contained 1 μM 
staurosporine unless otherwise noted.
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incorporated via on-resin alkylation of a se-
lectively deprotected cysteine residue (6). 
The resulting peptide was acetyl-capped at 
the N-terminus and included a C-terminal 
amide derived from the resin. Purification 
was carried out by standard reverse phase 
HPLC. Characterization was performed us-
ing ESI-MS, and concentrations were de-
termined based on the Sox chromophore 
using the absorbance of the peptide at 
355 nm in 0.1 M NaOH containing 1 mM 
Na2EDTA (extinction coefficient = 8,427 M
−1 
cm−1) (27).
MEF2A-CSox Reactions Containing 
Recombinant Enzyme. Reactions were 
carried out using 15 nM of the indicated en-
zyme (Invitrogen) and 1 μM MEF2A-CSox 
in a buffer containing 50 mM Tris-HCl (pH = 
7.5 at 25 °C), 10 mM MgCl2, 1 mM EGTA,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 mM DTT, 0.01% Triton X-100, and 1 mM 
ATP in a final volume of 120 μL. Well-to-
well path length variation was corrected by 
normalizing to starting intensities.
Determination of Kinetic Parameters 
of MEF2A-CSox with p38α and β. Reac-
tions were performed as above using 1 ng 
of recombinant human p38α or β (Invitro-
gen) with increasing concentrations of sub-
strate. Initial reaction slopes were then con-
verted to rates as described previously 
(27).
Recombinant Kinase Panel Assays. 
Reactions were conducted as described 
above with 1 μM MEF2A-CSox and 15 nM 
of the indicated kinase (Invitrogen).
Preparation of Cell Lysates. HeLa 
cells were propagated in 90% DMEM sup-
plemented with 10% heat-inactivated FBS, 
50 U mL−1 penicillin, and 50 μg mL−1 strep-
tomycin. Cos7 and NIH-3T3 cells were 
propagated in 90% DMEM supplemented 
with 10% FBS, 50 U mL−1 penicillin, and 
50 μg mL−1 streptomycin. Prior to stimula-
tion, cells were starved overnight (14 h) by 
the addition of DMEM supplemented with 2 
mM l-Gln, 50 U mL−1 penicillin, and 50 μg 
mL−1 streptomycin. Cells were stimulated 
by the addition of the indicated amount of 
TNFα (Cell Signaling) for 10 min or sorbitol 
to 300 mM for 1 h. Cells were then washed 
with ice-cold PBS and lysed on ice in 50 
mM Tris (pH = 7.5 at 25 °C), 150 mM NaCl, 
50 mM β-glycerophosphate, 10 mM sodium 
pyrophosphate, 30 mM NaF, 1% Triton 
X-100, 2 mM EGTA, 100 μM Na3VO4, 1 mM 
DTT, protease inhibitor cocktail III (10 μL 
mL−1, Calbiochem, 539134), and phospha-
tase inhibitor cocktail 1 (10 μL mL−1, Sigma, 
P2825). Lysates were clarified by centrifu-
gation, and supernatants were flash frozen 
in liquid nitrogen and stored at −80 °C.
Immunodepletions. Immunodeple-
tions were conducted as described previ-
ously (8). Briefly, sorbitol-stimulated HeLa 
lysates were aliquoted into separate sam-
ples (350 μg each) at 4 °C. Depletions were 
conducted using a rabbit anti-p38α (1 μg) 
antibody (Cell Signaling, 9218) along with a 
naïve rabbit IgG control (1 μg, GE Life Sci-
ences). Antibody-bound complexes were 
precipitated by the addition of Protein A 
agarose conjugated beads (GE Life Sci-
ences). Input (untreated) samples were 
used to determined the amount of activity 
lost due to handling, while a separate sam-
ple was treated with Protein A beads alone 
to determine the amount of activity lost 
due to nonspecific binding to the resin. Ly-
sates were flash frozen and stored at −80 
°C. ERK5 depletions were conducted in a 
similar manner using the appropriate an-
tibody (Cell Signaling, 3372). The rate of 
phosphorylation by off-target kinases was 
background-subtracted using the activ-
ity remaining after the addition of 1 μM 
SB203580 to the input lysates.
MEF2A-CSox Lysate Assays. As-
says were typically conducted using 1 μM 
MEF2A-CSox, 10 μg of total protein from 
cell lysates, and 1 μM staurosporine, un-
less otherwise indicated. Reactions were 
prepared in bulk in a buffer consisting of 50 
mM Tris-HCl (pH = 7.5 at 25 °C), 10 mM 
MgCl2, 1 mM EGTA, 2 mM DTT, and 0.01% 
Brij 35 P with the indicated concentration 
of p38α inhibitor and aliquoted into 96-well 
plates. After addition of lysate, reactions (fi-
nal volume 120 μL) were incubated at 30 
°C, and fluorescence emission was mon-
itored. Data were corrected for lag times 
(typically 5−10 min, after which fluores-
cence increases were linear with respect to 
time for at least 1 h) as well as variations in 
well-to-well path lengths. For titrations with 
SB203580, the calculated IC50 was con-
verted to a Ki value using the Cheng−Prus-
sof equation with the concentration of ATP 
in the assay and the reported KM of p38α 
Figure 4. MEF2A-CSox can selectively report on p38α activation in unfractionated cell ly-
sates. Dose-dependent responses to the addition of SB203580 (a) and BIRB796 (b) were 
observed in sorbitol-stimulated lysates (10 μg) using MEF2A-CSox (1 μM). The observed 
IC50 and structure of each compound are shown in the inset. c) Phosphorylation reactions 
were performed on lysates that had been depleted using a p38α-specific antibody. Val-
ues were background subtracted using the activity remaining in the input lysate after ad-
dition of 1 μM SB203580. The inset shows a Western blot of the immunodepleted lysates. 
d) The indicated cell lines were stimulated with 300 mM sorbitol for 1 h (S). Phosphoryla-
tion reactions were performed as above and compared to lysates from cells that had not 
been stimulated (C). The amount of p38α activity in each individual lysate was determined 
by subtracting the activity remaining after the addition of 1 μM SB203580. Western blots 
for both total and active p38 are shown above each sample. All reactions contained 1 μM 
staurosporine.
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for ATP (24). Slopes for assays contain-
ing the slow-binding inhibitor BIRB796 (25) 
were determined after a 10 min incubation 
of the entire solution at 30 °C. After this in-
cubation fluorescence increases were lin-
ear with respect to time for at least 1 h.
Slopes of phosphorylation reactions for 
assays containing lysates from different cell 
lines (Figure 4, panel d) were background 
corrected using the activity remaining in 
each individual lysate after the addition of 1 
μM SB203580.
Western Blot Analysis. Lysates (20 μg 
total protein unless noted) were separated 
by SDS-PAGE, and proteins were trans-
ferred to a nitrocellulose membrane. Blots 
were probed with primary antibodies for to-
tal p38 (Cell Signaling, 9212), phospho-p38 
(Cell Signaling, 9215), p38α, p38β (Cell 
Signaling, 2339), total ERK5 (Cell Signal-
ing, 3372), or phospho-ERK5 (Cell Signal-
ing, 3371, 300 μg of total protein used for 
blot), which were detected using an HRP 
conjugated goat anti-rabbit secondary anti-
body (Pierce, 32460). Blots were visualized 
by enhanced chemiluminescence (Pierce, 
34075).
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Supplementary Figure S1. MEF2A-CSox is a substrate for p38α. Initial phosphorylation 
reactions with and without the addition of kinase (15 nM) indicated that MEF2A-CSox (1 µM) 
was a substrate for p38α. 
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Supplementary Figure S2. Kinetic parameters of MEF2A-CSox for p38β. a) A direct fit of a 
velocity versus MEF2A-CSox concentration plot using the Briggs-Haldane equation (1 ng p38β). 
b) Kinetic parameters of MEF2A-CSox for the indicated kinases, demonstrating that MEF2A-
CSox is a more efficient substrate for p38α. Catalytic efficiency was determined using relative 
kcat/KM values.  
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Supplementary Figure S3. MEF2A-CSox phosphorylation varies with TNFα stimulation. a) 
Fluorescence slopes of reactions conducted without staurosporine using 1 µM substrate and 5 
µg of HeLa lysates derived from cells stimulated for 10 min with the indicated amount of TNFα. 
Assays were also performed with lysates from untreated (serum starved) cells. b) The 
relationship between MEF2A-CSox phosphorylation and the amount of TNFα used for 
stimulation. c) A western blot of the indicated lysates with the corresponding antibodies, 
demonstrating increased phosphorylation of p38 with increasing amounts of TNFα.  
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Supplementary Figure S4. Staurosporine does not significantly alter p38α activity (1). 
Reactions were performed using 1 nM recombinant p38α and 1 µM substrate.  
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Supplementary Figure S5. The effect of the amount of lysate used in the assay on the rate of 
phosphorylation of MEF2A-CSox. a) Reactions conducted with 1 µM substrate and the indicated 
amount of serum starved and sorbitol-stimulated HeLa lysates. b) The fold change in reaction 
slope between sorbitol-stimulated and serum starved lysates with respect to the amount of 
lysate used in the assay. The assay is most sensitive when 10 µg of lysate is used. Presumably 
the sensitivity of the assay decreases with increasing concentrations of lysate due to the 
increasing amounts of off-target kinases. All reactions contained 1 µM staurosporine. 
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Supplementary Figure S6. The addition of 1 µM SB203580 or BIRB796 completely abolishes 
recombinant p38α activity. Reactions were conducted with 1 µM substrate and 1 nM 
recombinant enzyme. Slopes for assays containing the slow-binding inhibitor BIRB796 were 
determined after incubation of the entire reaction at 30 oC for 30 min prior to data collection, 
after which fluorescence increases were linear with respect to time.  
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Supplementary Figure S7. The inhibitor solvent, DMSO, does not influence the 
phosphorylation of MEF2A-CSox. Assays were conducted using 1 µM MEF2A-CSox and 10 µg 
of sorbitol-stimulated HeLa lysates with the indicated inhibitor. All reactions contained 1 µM 
staurosporine. 
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Supplementary Figure S8. The related ERK5 kinase does not significantly contribute to the 
phosphorylation of MEF2A-CSox (1 µM) in sorbitol-stimulated HeLa cell lysates. a) Western blot 
analysis of sorbitol-stimulated lysates demonstrating activation of ERK5. b) Immunodepletion of 
p38α leads to a dramatic decrease in MEF2A-CSox phosphorylation (left) while depletion of 
ERK5 demonstrated no significant loss of signal (right). Values were background subtracted 
using the activity remaining in the input lysates after addition of 1 µM SB203580. Western blots 
of the respective lysates demonstrating depletion of the target kinase are shown in the insets of 
each panel. Note that p38β levels remain unchanged, indicating that the remaining MEF2A-
CSox activity is likely due to residual p38α (~30% remaining by gel densitometry). All reactions 
contained 1 µM staurosporine. 
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Supplementary Table S1. Reported dissociation constants of SB203580, BIRB796, and 
staurosporine for the indicated kinase are given (1). 
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